List of works - Hanna Dams-Kozlowska

A designer hyper interleukin 11 (H11) is a biologically active cytokine.

scientific article

Bioengineering the spider silk sequence to modify its affinity for drugs

Blending two bioengineered spider silks to develop cancer targeting spheres

scientific article published on 05 April 2017

Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model

scientific article published on 01 June 2015

Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres

scientific article published on 26 August 2019

Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.

scientific article published on 15 July 2019

Construction of a chimeric gene cluster for the biosynthesis of apoemulsan with altered molecular weight

scientific article

Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins

scientific article published on 17 January 2018

Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor

scientific article

Discovery of the dual polysaccharide composition of emulsan and the isolation of the emulsion stabilizing component

scientific article published on 12 June 2008

Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells

scientific article published on 30 March 2020

Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice

scientific article

Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.

scientific article

Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo

scientific article published on 01 December 2020

Functionalized spider silk spheres as drug carriers for targeted cancer therapy

scientific article

Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironment.

scientific article published on 22 December 2017

Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.

scientific article published on 14 October 2011

Implementation of a dynamic culture condition to the heterotypic 3D breast cancer model

scientific article published on 16 August 2019

Influence of deletions in the apoemulsan gene cluster on A. venetianus RAG-1 polysaccharide biosynthesis.

scientific article published in December 2008

Modifications and applications of the Acinetobacter venetianus RAG-1 exopolysaccharide, the emulsan complex and its components.

scientific article published on 16 September 2008

Oncogenomic portals for the visualization and analysis of genome-wide cancer data

scientific article

Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics

scientific article published on 22 September 2018

Peptide-functionalized ZCIS QDs as fluorescent nanoprobe for targeted HER2-positive breast cancer cells imaging

scientific article published on 2 February 2016

Protein engineering of wzc to generate new emulsan analogs

scientific article published on 20 April 2007

Purification and cytotoxicity of tag-free bioengineered spider silk proteins

scientific article published on 3 August 2012

Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells.

scientific article published on 19 September 2016

Silk Materials Functionalized via Genetic Engineering for Biomedical Applications.

scientific article published on 12 December 2017

Silk Particles as Carriers of Therapeutic Molecules for Cancer Treatment

scientific article published on 04 November 2020

Silk as an innovative biomaterial for cancer therapy

scientific article

The method of purifying bioengineered spider silk determines the silk sphere properties.

scientific article published on 17 June 2016

[Engineered spider silk: the intelligent biomaterial of the future. Part II]

scientific article published on 17 June 2011

[Engineered spider silk: the intelligent biomaterial of the future. Part I]

scientific article published on 17 June 2011

List of works by Hanna Dams-Kozlowska

A designer hyper interleukin 11 (H11) is a biologically active cytokine.

Bioengineering the spider silk sequence to modify its affinity for drugs

Blending two bioengineered spider silks to develop cancer targeting spheres

Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model

Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres

Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.

Construction of a chimeric gene cluster for the biosynthesis of apoemulsan with altered molecular weight

Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins

Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor

Discovery of the dual polysaccharide composition of emulsan and the isolation of the emulsion stabilizing component

Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells

Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice

Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.

Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo

Functionalized spider silk spheres as drug carriers for targeted cancer therapy

Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironment.

Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell cancer vaccines.

Implementation of a dynamic culture condition to the heterotypic 3D breast cancer model

Influence of deletions in the apoemulsan gene cluster on A. venetianus RAG-1 polysaccharide biosynthesis.

Modifications and applications of the Acinetobacter venetianus RAG-1 exopolysaccharide, the emulsan complex and its components.

Oncogenomic portals for the visualization and analysis of genome-wide cancer data

Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics

Peptide-functionalized ZCIS QDs as fluorescent nanoprobe for targeted HER2-positive breast cancer cells imaging

Protein engineering of wzc to generate new emulsan analogs

Purification and cytotoxicity of tag-free bioengineered spider silk proteins

Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells.

Silk Materials Functionalized via Genetic Engineering for Biomedical Applications.

Silk Particles as Carriers of Therapeutic Molecules for Cancer Treatment

Silk as an innovative biomaterial for cancer therapy

The method of purifying bioengineered spider silk determines the silk sphere properties.

[Engineered spider silk: the intelligent biomaterial of the future. Part II]

[Engineered spider silk: the intelligent biomaterial of the future. Part I]